Pfizer offers $100m to buy Brisbane company behind smartphone app that diagnoses COVID-19
Pfizer offers $100 million to buy a ResApp, a company that has invented a smartphone app it says can diagnose COVID-19 by listening to someone cough.
ABC News ·